Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy
Highlights We classified the carriers that built cancer nanovaccines, discussed their diversified applications and coincidently compared their advantages and disadvantages. Various cellular targets that guide the design and engineering of cancer nanovaccines are categorized and their characteristics...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2024-09-01
|
| Series: | Nano-Micro Letters |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40820-024-01533-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849234759347077120 |
|---|---|
| author | Yijie Wang Congrui Liu Chao Fang Qiuxia Peng Wen Qin Xuebing Yan Kun Zhang |
| author_facet | Yijie Wang Congrui Liu Chao Fang Qiuxia Peng Wen Qin Xuebing Yan Kun Zhang |
| author_sort | Yijie Wang |
| collection | DOAJ |
| description | Highlights We classified the carriers that built cancer nanovaccines, discussed their diversified applications and coincidently compared their advantages and disadvantages. Various cellular targets that guide the design and engineering of cancer nanovaccines are categorized and their characteristics and benefits are highlighted. The clinical cases and encountered challenges in cancer nanovaccines are discussed, during which reasonable solutions and future research direction are provided. |
| format | Article |
| id | doaj-art-472fe406c284487ea43009b53602a1fd |
| institution | Kabale University |
| issn | 2311-6706 2150-5551 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Nano-Micro Letters |
| spelling | doaj-art-472fe406c284487ea43009b53602a1fd2025-08-20T04:03:02ZengSpringerOpenNano-Micro Letters2311-67062150-55512024-09-0117113510.1007/s40820-024-01533-yEngineered Cancer Nanovaccines: A New Frontier in Cancer TherapyYijie Wang0Congrui Liu1Chao Fang2Qiuxia Peng3Wen Qin4Xuebing Yan5Kun Zhang6Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of ChinaCentral Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of ChinaCentral Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of ChinaCentral Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of ChinaCentral Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of ChinaJiangsu Provincial Innovation and Practice Base for Postdoctors, Suining People’s Hospital, Affiliated Hospital of Xuzhou Medical UniversityCentral Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of ChinaHighlights We classified the carriers that built cancer nanovaccines, discussed their diversified applications and coincidently compared their advantages and disadvantages. Various cellular targets that guide the design and engineering of cancer nanovaccines are categorized and their characteristics and benefits are highlighted. The clinical cases and encountered challenges in cancer nanovaccines are discussed, during which reasonable solutions and future research direction are provided.https://doi.org/10.1007/s40820-024-01533-yCancer nanovaccinesImmunotherapyNanobiotechnologyImmune targetsSignaling pathway |
| spellingShingle | Yijie Wang Congrui Liu Chao Fang Qiuxia Peng Wen Qin Xuebing Yan Kun Zhang Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy Nano-Micro Letters Cancer nanovaccines Immunotherapy Nanobiotechnology Immune targets Signaling pathway |
| title | Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy |
| title_full | Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy |
| title_fullStr | Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy |
| title_full_unstemmed | Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy |
| title_short | Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy |
| title_sort | engineered cancer nanovaccines a new frontier in cancer therapy |
| topic | Cancer nanovaccines Immunotherapy Nanobiotechnology Immune targets Signaling pathway |
| url | https://doi.org/10.1007/s40820-024-01533-y |
| work_keys_str_mv | AT yijiewang engineeredcancernanovaccinesanewfrontierincancertherapy AT congruiliu engineeredcancernanovaccinesanewfrontierincancertherapy AT chaofang engineeredcancernanovaccinesanewfrontierincancertherapy AT qiuxiapeng engineeredcancernanovaccinesanewfrontierincancertherapy AT wenqin engineeredcancernanovaccinesanewfrontierincancertherapy AT xuebingyan engineeredcancernanovaccinesanewfrontierincancertherapy AT kunzhang engineeredcancernanovaccinesanewfrontierincancertherapy |